Drug Database
Back to search

Poland· PL-100351720

ApoSuprid

A amisulpride product containing amisulpridum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC N05AL05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedApoSupridATCN05AL05REGISTER NO.PL-100351720PACKS LISTED9CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amisulpridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amisulpride is registered in 14 of 19 countries.

Countries holding a registration under ATC N05AL05 (amisulpride), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search amisulpride products by name

Amisulpride · ATC N05AL05

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amisulpride costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.37 in France to $2.49 in Switzerland — a ×1.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Amisulpride · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.49
  • IT Italy$1.87
  • FR France$1.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Amisulpridum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
N05AL05
ATC class
Amisulpride
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

1 priced
  • gtin
    05909991348649
    30 szt.
    PLN 113.21
  • gtin
    05909991348663
  • gtin
    05909991348670
  • gtin
    05909991348687
  • gtin
    05909991348694
  • gtin
    05909991348700
  • gtin
    05909991348625
  • gtin
    05909991348632
  • gtin
    05909991348656

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for amisulpride.

Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amisulpride against other medicinesHow interaction checks work

Amisulpride · interactions on record

228 records

  • 126 severe
  • 49 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe

51 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amisulpride in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amisulpride products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Amisu, Solian
  • Belgium · Amisulpride Eg, Solian
  • Bulgaria · Alonet, Медосулпид
  • Cyprus · Aktiprol, Solian
  • Czechia · Aktiprol, Amilia
  • Germany · Amisulprid Aaa, Amisulprid Mylan
  • Denmark · Aktiprol, Amisulprid Dlf
  • Estonia · Amisan, Solian
  • Spain · Amisulprida Aurovitas, Amisulprida Normon
  • France · Amisulpride Arrow Lab, Amisulpride Biogaran
  • United Kingdom (Northern Ireland) · Amisulpride, Amisulpride Accord-Uk
  • Greece · Isofredil, Nodasic
  • Croatia · Aktiprol, Solian
  • Hungary · Amisulprid Ratiopharm, Amitrex
  • Ireland · Amisulpride Mylan, Solian
  • Iceland · Solian
  • Italy · Amisulpride Aurobindo, Amisulpride Doc
  • Lithuania · Aktiprol, Amisan
  • Luxembourg · Amisulpride Eg, Solian
  • Latvia · Aktiprol, Solian
  • Malta · Aktiprol, Amisulpride Syri Pharma
  • Netherlands · Aktiprol
  • Norway · Solian
  • Portugal · Amissulprida Aurobindo, Amissulprida Aurovitas
  • Romania · Masultab, Midora
  • Slovenia · Solian
  • Slovakia · Aktiprol, Amisulprid Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ffddad45-810b-4a7e-9554-21e41e36c939
GET /v1/drugs/ffddad45-810b-4a7e-9554-21e41e36c939?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909991348625 ¦ Rp ¦ 124824\n15 tabl.\n05909991348632 ¦ Rp ¦ 124825\n20 tabl.\n05909991348649 ¦ Rp ¦ 124826\n30 tabl.\n05909991348656 ¦ Rp ¦ 124827\n50 tabl.\n05909991348663 ¦ Rp ¦ 124828\n60 tabl.\n05909991348670 ¦ Rp ¦ 124829\n80 tabl.\n05909991348687 ¦ Rp ¦ 124830\n100 tabl.\n05909991348694 ¦ Rp ¦ 124831\n120 tabl.\n05909991348700 ¦ Rp ¦ 124832\n150 tabl.",
  "substance": "Amisulpridum 400 mg",
  "common_name": "Amisulpridum",
  "pl_product_id": "100351720",
  "pozwolenie_nr": "24297",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about amisulpride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console